Columbia Banking System is a defensive Western US regional bank recovery: it trades at just 1.18x book with a beta of 0.68, sits below resistance rather than extended, has posted four straight earnings beats and runs clean credit. This is an actionable A+ with a genuinely low-beta profile — exactly the kind of name that works in a neutral, choppy tape.Q1 2026 transcript· avr 2026
Columbia Banking System (NASDAQ: COLB) is the holding company for Umpqua Bank, the premier business bank in the Western US. It was created by the 2023 merger of Columbia and Umpqua Holdings, and is now a top-30 US bank by assets, headquartered in Tacoma, Washington with an eight-state footprint across the West.PR Newswire· mars 2023
On August 31, 2025 Columbia completed its all-stock acquisition of Pacific Premier Bancorp (~$2.0B), pushing total assets to roughly $66 billion and deepening its leadership in the largest Western banking markets. The franchise is a classic commercial relationship bank: gather low-cost deposits, lend to regional businesses, and harvest a wide net interest margin. Management has since pivoted to core lending and shareholder payouts — exactly the "boring, profitable" posture investors want from a regional after a big integration.PR Newswire· sept 2025
| Metric | Value | Signal |
|---|---|---|
| Total Revenue (Q1'26) | $677M | In line |
| Net Interest Margin (NIM) | 3.96% | Guided >4% Q2 |
| Operating EPS (Q1'26) | $0.72 | Beat $0.686 |
| ROTCE | >15% | Strong |
| ROAA | 1.3% | Healthy |
| Efficiency Ratio | 53.7% | Lean |
| CET1 Capital | 11.5% | Well-capitalized |
| Price / Book | 1.18x | Value |
| Quarterly Dividend | $0.37 | 4.7% yield |
| Buyback Remaining | $400M | $150-200M/qtr pace |
For a bank, NIM, ROTCE and the efficiency ratio matter more than margins or EBITDA. COLB earns a 3.96% NIM (guided above 4% in Q2), a 15%+ ROTCE and runs a lean 53.7% efficiency ratio — meaning it spends under 54 cents to earn a dollar of revenue. With CET1 at 11.5% it is comfortably above regulatory minimums, which is what funds the dividend and the active buyback ($400M remaining on a $700M authorization, ~$200M repurchased in Q1 alone).
| RSI (14) | 66.8 |
| EMA 20 | $29.82 |
| EMA 50 | $29.39 |
| EMA 200 | $28.15 |
| MACD | 0.360 |
| Signal | 0.190 |
| ATR (14) | $0.68 |
Clean rising structure: EMA20 ($29.82) > EMA50 ($29.39) > EMA200 ($28.15), all sloping up — a textbook stacked-EMA uptrend. At $31.31 the stock sits roughly 5% above its EMA20, so it is firm but not parabolic; the rising EMA20/EMA50 cluster offers a logical support shelf just below. MACD is bullish (0.36 over 0.19). The one yellow flag is RSI at 66.8 — the top of the healthy band, so a near-term pause or shallow pullback toward the EMA20 would be normal and is where the actionable entry lives.Finviz· live
A well-capitalized, low-beta regional bank with clean credit and a 4.7% yield. The principal risks are sector-level — CRE exposure and deposit competition — plus a near-term technical stretch with RSI at the top of its band.
COLB carries the usual regional-bank labels — CRE and deposit-cost sensitivity — but the balance sheet is well-capitalized (CET1 11.5%), credit is clean, and the beta of 0.68 means the stock moves about a third less than the market. The buyback and dividend put a floor under the equity. The realistic near-term risk is simply that RSI 66.8 triggers a pause, which is exactly why the trade is built at an entry near support rather than chasing.GuruFocus· avr 2026
This is the actionable part: COLB is not over-extended, so the trade is built near spot. Use a limit at $31.10 (~0.7% below the live $31.31, into the rising EMA20/EMA50 cluster), stop at $29.95 — under the round number and above EMA50 ($29.39), about 1.7× ATR. That puts $1.15 of risk against $2.10 to TP1 at $33.20, a clean 1:1.83 reward-to-risk, expanding to 1:3.4 at the $35.00 stretch. If instead you fill at the current market ($31.31), the math tightens to ~1:1.39 to TP1, so the limit entry — not a chase — is what preserves the edge; be patient for the fill. The fundamental engine — operating ROTCE near 18%, NIM guided above 4%, an active buyback ($400M remaining) at 1.18x book and just a 9.3x forward P/E — is what carries price from a defensive base while the 0.68 beta keeps drawdowns contained. One honest caveat on the targets: TP1 at $33.20 sits just above the Street's median 12-month target (~$32.50) and the 52-week high ($32.70), and consensus is a "Hold," so TP1 requires a fresh breakout — TP2 at $35 is a genuine stretch.Analyst targets· live
This analysis is provided for informational and educational purposes only. It does not constitute financial advice, investment recommendation, or solicitation to buy or sell any security.
Past performance is not indicative of future results. All investments involve risk, including the possible loss of principal. Always conduct your own research and consult a licensed financial advisor before making investment decisions.
Data sourced from DailyTickers Gateway, Yahoo Finance, SEC EDGAR, and public market data. Accuracy is not guaranteed.